Content Loading...
Content Loading...
Last Item Added: 0 Items
Content Loading...
» Close


Millipore Corporation is pleased to announce the acquisition of key Alzheimer’s disease research products from The Genetics Company of Zurich, Switzerland. These products further support our extensive portfolio of Alzheimer’s disease reagents and represent Millipore’s continued commitment to excellence in neuroscience research. These key products include highly purified monoclonal antibodies and were developed in collaboration with leading Alzheimer’s disease researchers.

Highly selective, these antibodies specifically recognize beta-Amyloid peptides and are ideal for use in Western blotting, IH, ELISA and other applications, ensuring highly reproducible results.


Now Available
Millipore Catalog #DescriptionSize
MABN10Anti-human Amyloid β, clone WO-250 μg
MABN11Anti-human Amyloid β, clone G2-1050 μg
MABN12Anti-human Amyloid β, clone G2-1150 μg
MABN13Anti-human Amyloid β, clone G2-1350 μg

  • Click here to view additional Amyoid beta antibodies
  • Click here to view our complete list of Alzheimer’s related reagents
For ordering information call 1-800-millipore or contact your local Millipore Account Manager.